PASSERI DANIEL R (CEO and President) purchased 22.3% of their position (30K shares) of CUE BIOPHARMA, INC. on the open market
Open‑market purchase worth $30.9K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 12/18/2024ACC: 0000950170-24-137860
DirectorOfficer· CEO and President
Since Aug 2018
+30K
Net shares
Net buyer
$30.9K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
30K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+30K
Price / share
$1.03
Trade value
$30.90K
% of position
22.3%
12/16/2024
134.58K→164.58K
Total
Net shares
+30K
Net value
$30.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/16/2024 | P · Purchase | +30K | $1.03 | $30.90K | 22.3% | 134.58K | 164.58K |
| Total | +30K | $30.90K | ||||||
Derivative Transactions0
No derivative transactions reported